08/10/22 8:23 PMNasdaq : EVFM conferenceshigh shortEvofem Biosciences to Host Investor Call on Thursday, August 11, 2022Evofem Biosciences, Inc., (EVFM) will hold an investor call as follows:Date:Thursday, August 1 1, 2022Time:5:00 p.m. ET (2:00 p.m. PT)Live call:(877) 4 45-9755 (U.S. toll-free) or(2 01)RHEA-AIneutral
08/04/22 4:01 PMNasdaq : EVFM earningshigh shortEvofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 GuidanceCompleted registrational Phase 3 trial evaluating Phexxi for the prevention of chlamydia andRHEA-AIneutral
08/03/22 8:24 AMNasdaq : EVFM managementhigh shortEvofem Biosciences Strengthens Board of DirectorsEvofem Biosciences, Inc., (Nasdaq: EVFM) today announced the appointment of Jenny Yip, a Managing Partner at life sciences investment fund Adjuvant Capital, to its Board of Directors. The appointment of Ms. Yip as a director expands the Board from five toRHEA-AIneutral
08/01/22 8:47 AMNasdaq : EVFM clinical trialhigh shortEvofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 "EVOGUARD" Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in WomenEvofem Biosciences,RHEA-AIneutral
07/29/22 8:24 AMNasdaq : EVFM high shortEvofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to IndividualsEvofem Biosciences, Inc., (Nasdaq: EVFM), a women's healthcare company, today commended the U.S. Department of Health and Human Services, alongside the Departments of Labor and of the Treasury ("the Tri-Agencies"), for taking action to clarify protectionsRHEA-AIneutral
07/28/22 8:47 AMNasdaq : EVFM conferenceshigh shortEvofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the second quarter ended June 30, 2022 as follows:Date:Thursday,RHEA-AIneutral
07/26/22 8:47 AMNasdaq : EVFM high shortEvofem's House Rules Campaign Featuring Annie Murphy Receives Significant Industry RecognitionEvocative direct-to-consumer (DTC) campaign has received 12 healthcare and communications industry awards to date and has recently been shortlisted for four more awards. The national campaign features Emmy ® Award-winning spokeswoman and actress Annie Murphy and was created to generate awareness ofRHEA-AIvery positive
07/25/22 8:47 AMNasdaq : EVFM high shortEvofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive CounselingEvofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has developed a new educational birth control chart that provides high-level information about the different options available to women in the United States."Contraceptive counseling is one ofRHEA-AIneutral
07/22/22 8:47 AMNasdaq : EVFM high shortEvofem Biosciences Applauds U.S. House of Representatives for Passing The Right to Contraception ActEvofem Biosciences, Inc., (Nasdaq: EVFM), a women's healthcare company, today applauded the 228 members of the U.S. House of Representatives who voted to pass legislation to safeguard access to contraceptives entitled The Right to Contraception Act."TodayRHEA-AIneutral
07/21/22 8:46 AMNasdaq : EVFM partnershiphigh shortEvofem Partners with a360 Media to Support Phexxi® Prescription GrowthRHEA-AIvery positive